New Pediatric Codes for 2019: Focus on Revised E/M Codes

Don’t overlook important CPT code changes for developmental screenings

Significant changes to the 2019 Current Procedural Terminology (CPT®) code set will have you scrambling to revamp your billing processes for Evaluation and Management (E/M) services. Find out which codes will look different come January 1, 2019—and how the changes will affect your pediatrics office. More..

Urology CPT Codes

New Urology CPT Codes Focus on Endourology

Important: Don’t overlook changes to E/M codes and PFS

CPT codes for urologists and genitourinary procedures didn’t see a whole lot of action in the 2019 coding updates, but you still need to make sure you’re not ignoring the few crucial coding changes that will impact your practice. And among the new, revised, and More..

OTC Drug

OTC Drug Compliance Reform Act Will Impact Your Current & Future Offerings

Good news: This OTC Monograph legislation, now stalled in Senate, could help you innovate

Manufacturers of over-the-counter (OTC) drugs: Get ready for change. The Over-the-Counter Drug Safety, Innovation, and Reform Act promises to modify the regulatory system that oversees most OTC medications—and the OTC Monograph system. Anyone who develops and produces an OTC drug for marketing and sale in More..

Ortho Audits

Ortho Audits: Prepare for Intense Scrutiny of Your E&M Documentation

Plus: Be sure you’re prepped for orthopedics ICD-10 & CPT code changes for 2019

If your medical record documentation is lacking, you likely cannot support a higher Evaluation and Management (E&M) level of service—which may lead to lost revenue for orthopedic services. And although the Centers for Medicare & Medicaid Services (CMS) is pondering a major makeover for E&M More..


Heed New ANDA Requirements—Or Risk a Swift FDA Rejection

The agency has no tolerance for incomplete or inadequate submissions

Submitting Abbreviated New Drug Applications (ANDA), especially now, is no straightforward matter. The U.S. Food and Drug Administration (FDA) just released new Generic Drug User Fee Amendments (GDUFA) guidance and yet ANDA submitters are still encountering plenty of ambiguity—even while the FDA is cracking down More..


Urology Reimbursement Booster: Untangle Split/Shared & ‘Incident To’ Office Visits

Yes, you’re missing out on revenue from these overlooked services

If you’re looking for sources of reimbursement for urology visits that you haven’t billed in the past, you’re in luck. Uncover the overlooked services that can lead to increased, deserved reimbursement for your urology practice. Mistake: Urologists often fail to bill for or correctly code More..